As of 2026-09-19, the Intrinsic Value of Atossa Therapeutics Inc (ATOS) is -18.91 USD. This Atossa valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.22 USD, the upside of Atossa Therapeutics Inc is -951.86%.
Based on its market price of 2.22 USD and our intrinsic valuation, Atossa Therapeutics Inc (ATOS) is overvalued by 951.86%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -18.91 - -18.91 | -18.91 | -951.86% |
| P/E | (30.33) - (77.99) | (65.62) | -3055.9% |
| DDM - Stable | (22.47) - (70.08) | (46.28) | -2184.5% |
| DDM - Multi | (17.80) - (45.23) | (25.78) | -1261.1% |
| Market Cap (mil) | 22.13 |
| Beta | 1.69 |
| Outstanding shares (mil) | 9.97 |
| Enterprise Value (mil) | -3.96 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.32% |
| Cost of Debt | 5.00% |
| WACC | 7.99% |